Latest Market Segments News

ECS Botanics reports a third straight quarter of positive operating cash flow, driven by strong B2C growth and strategic international shipments to Germany and New Zealand.

Bio-Gene Technology is progressing critical toxicology studies for Flavocide with a targeted APVMA submission in March 2027, while forging a strategic partnership to launch Qcide insecticides in Japan by late 2026.

InteliCare has inked a $200,000 contract to deploy its AI-powered monitoring platform across 65 retirement villas at Warrigal's new development, marking its first foray into the retirement living sector with potential for wider rollout.

Metal Powder Works nearly doubled its powder revenue in Q1 2026 while maintaining strong margins, secured its first NATO defence contract under the UK Ministry of Defence’s Project TAMPA, and advanced its Next Gen powder production system on schedule.

MoneyMe's loan book has surged to $1.9 billion, driving a positive Normalised NPAT in 3Q26 as the fintech lender expands into credit cards with a new launch and a Luxury Escapes partnership.

Iluka Resources scaled back mineral sands output in Q1 2026 amid operational idling and market caution, while capital expenditure on its Eneabba rare earths refinery hit $977 million with commissioning progressing.

Kinatico Ltd has reported a 30% year-on-year rise in SaaS revenue to $5.2 million for Q3 FY26, with EBITDA up 27% amid extended sales cycles and economic uncertainty. The company’s AI-native compliance platform is well positioned for regulatory tailwinds starting July 2026.

Netwealth delivered a resilient March quarter with $4 billion in net inflows, pushing total funds under administration to $125.8 billion despite a 3.7% market dip. Growth in Managed Accounts and new intermediary relationships underpin ongoing momentum.

Michael Hill International’s 2026 Investor Day highlights sustained sales growth, a streamlined brand portfolio, and a disciplined return to dividends, underpinned by AI-driven retailing and a reset of the Bevilles brand.

Xref Limited has unveiled Xref.me, a pioneering platform that transforms recruitment by shifting to verified digital resumes at application, unlocking new pay-per-access revenue streams and expanding its enterprise SaaS funnel.

Mesoblast Limited (ASX:MSB, Nasdaq:MESO) reported net sales of US$30.3 million for its FDA-approved cellular therapy Ryoncil in the March quarter, bringing total revenue since launch close to US$100 million. Strong sales in February and March offset January’s seasonal dip.

The Environmental Group’s TAPC division has secured a significant A$9 million contract to supply emissions control technology for a key rare earth project in Angola, marking a strategic move into the critical minerals sector.